首页> 美国卫生研究院文献>International Journal of Surgery Case Reports >Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature
【2h】

Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature

机译:JAK2突变患者因脾门轴血栓形成而导致的上消化道大出血:一例病例报告并复习文献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Portal hypertension is a clinical syndrome defined as a portal venous pressure that exceeds 10 mmHg. Cirrhosis is the most common cause of portal hypertension and thrombosis of the splenoportal axis not associated with liver cirrhosis is the second cause of portal hypertension in the Western world. The primary myeloproliferative disorders are the main cause of portal venous thrombosis and somatic mutation of Janus Kinase 2 gene (JAK2 V617F) can be found in approximately 90% of polycythemia vera, 50% of essential thrombocyrosis and 50% primary myelofibrosis. A a 55-year-old man with JAK2 mutation-associated splenoportal axis hypertension and bleeding complications due to oesophageal varices is reported. A massive upper bleeding episode made an emergent surgery to be done immediatelly at seventh day. The patient was discharged home at fifteenth day after surgery.
机译:门静脉高压症是一种临床综合征,其定义为门静脉压力超过10毫米汞柱。肝硬化是门脉高压的最常见原因,而与肝硬化无关的脾门轴血栓形成是西方世界门脉高压的第二个原因。原发性骨髓增生性疾病是门静脉血栓形成的主要原因,Janus Kinase 2基因(JAK2 V617F)的体细胞突变可在大约90%的真性红细胞增多症,50%的原发性血小板增多症和50%的原发性骨髓纤维化中发现。据报道,一名55岁的男性患有JAK2突变相关的脾门静脉高压症,并因食管静脉曲张引起出血并发症。大量的上出血事件在第七天立即进行了紧急手术。病人在手术后第十五天出院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号